Medical News

RSS

UT Arlington electrical engineer developing low-power integrated circuit for directional hearing aids

A University of Texas at Arlington electrical engineering researcher is developing a more efficient, low-power integrated circuit for directional hearing aids that will lead to a better quality of life for hearing impaired people.

1 Apr 2015

Neurocrine Biosciences, Mitsubishi Tanabe to develop and commercialize NBI-98854 in select Asian markets

Neurocrine Biosciences, Inc. today announced that it has entered into an exclusive collaboration and licensing agreement for the development and commercialization of its VMAT2 inhibitor, NBI-98854, in Japan and other select Asian markets with Mitsubishi Tanabe Pharma Corporation.

1 Apr 2015

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

31 Mar 2015

Antibodies may trigger psychiatric illness in children

A world first study revealing the presence of two antibodies in a sub-group of children experiencing their first episode of psychosis affirms a longstanding recognition that auto-immune disorders play a significant role in psychiatric illness.

31 Mar 2015

Patient's own skin cells may hold key to new treatments for neurological diseases

A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.

31 Mar 2015

New osteoporosis drug may also be useful for treating brittle bone disease

New research at the University of Michigan offers evidence that a drug being developed to treat osteoporosis may also be useful for treating osteogenesis imperfecta or brittle bone disease, a rare but potentially debilitating bone disorder that that is present from birth.

31 Mar 2015

ATI Physical Therapy acquires Flexeon Rehabilitation

ATI Physical Therapy today announces the acquisition of Flexeon Rehabilitation, a 16 clinic practice with locations in Chicagoland and Northwest Indiana. ATI is the nation's largest physical therapy practice under one brand, and recently expanded into the state of Nevada with the addition of 12 clinics in the Las Vegas area.

31 Mar 2015

WGU Texas announces new scholarship program for nurses

To honor nurses for their commitment to community health and to commemorate upcoming National Nurses Week 2015, WGU Texas has announced the WGU Texas Loves Nurses Scholarship.

31 Mar 2015

New Orthopaedic & Spine Center guide discusses conservative treatment options for hip, knee and spine pain

The physicians at Orthopaedic & Spine Center have put together an information guide – Surgery Isn't Always the Answer. The resource discusses conservative treatment options for those who suffer from hip, knee, and spine pain. The guide also shares information on the benefits of early diagnosis and minimally-invasive surgical treatments.

31 Mar 2015

Northwestern Medicine opens multidisciplinary treatment center for patients battling Huntington's disease

Northwestern Medicine recently launched a multidisciplinary center dedicated to the comprehensive treatment of patients battling Huntington's disease. The new center will focus on both patient care and research of the inherited disease that causes the progressive breakdown of nerve cells in the brain.

31 Mar 2015

Study suggests possible role for caffeine in AD treatment

The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

31 Mar 2015

Good Samaritan Hospital's Stroke Program certified as primary stroke center

Good Samaritan Hospital's Stroke Program has attained The Joint Commission's Gold Seal of Approval® and the American Heart Association/American Stroke Association's Heart-Check mark as a certified primary stroke center. The recognition means the Stroke Program has met The Joint Commission's standards for providing stroke care.

31 Mar 2015

ITOCHU CHEMICAL FRONTIER makes strategic investment in SCILEX Pharmaceuticals

SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced that ITOCHU CHEMICAL FRONTIER Corporation (ICF, Tokyo Japan), a member of ITOCHU Corporation, one of the three leading sogo shosha (general trading companies) in Japan, has made a strategic investment in SCILEX.

31 Mar 2015

Aspen Dental to open five new locations in Arkansas in 2015

Access to dental care in Arkansas is about to get a healthy boost with the addition of five new Aspen Dental–branded practices, the first of which will open in Searcy and Jonesboro on Thursday, April 9.

31 Mar 2015

New web-based platform launched to provide acne care to patients across Pennsylvania

Dr. Jamie Altman, owner and president of Aesthetic Dermatology Associates, PC, a dermatology practice based in the Philadelphia suburbs of Media and Paoli, today announced the launch of AcneCareMD.com, a secure telemedicine website designed to provide acne care to patients across Pennsylvania via a web-based platform.

31 Mar 2015

MOVANTIK (naloxegol) now available in U.S. for treatment of OIC in adult patients with non-cancer pain

Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.

31 Mar 2015

Jacoti releases first FDA-registered medical device hearing aid application for smartphones

Jacoti bvba announced today the US release of Jacoti ListenApp, the first FDA registered and CE certified medical device hearing aid application for smartphones. Indicated for mild to moderate hearing loss, ListenApp precisely adjusts the sound of an iOS device to the user's audiogram, transforming the device into a sophisticated, flexible and very affordable hearing instrument with extremely high sound quality.

31 Mar 2015

Mylan announces U.S. launch of Amlodipine and Valsartan Tablets

Mylan N.V. today announced the U.S. launch of Amlodipine and Valsartan Tablets, 5 mg/160 mg, 5 mg/320 mg, 10 mg/160 mg, 10 mg/320 mg, which is the generic version of Novartis' Exforge Tablets.

31 Mar 2015

Research reveals stark variation in genetic tests for inherited eye disease in England

New research from The University of Manchester published in the Journal of Community Genetics reveals a stark variation in genetic testing services for inherited eye disease in England.

31 Mar 2015

Moon does not influence timing of human births, hospital admissions, says UCLA scientist

"It must be a full moon" is a common refrain when things appear more hectic than usual. The moon is even blamed when things get crazy at hospital emergency rooms or birth wards. "Some nurses ascribe the apparent chaos to the moon, but dozens of studies show that the belief is unfounded," said Jean-Luc Margot, a UCLA professor of planetary astronomy.

31 Mar 2015

Medical News

UT Arlington electrical engineer developing low-power integrated circuit for directional hearing aids

Neurocrine Biosciences, Mitsubishi Tanabe to develop and commercialize NBI-98854 in select Asian markets

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Antibodies may trigger psychiatric illness in children

Patient's own skin cells may hold key to new treatments for neurological diseases

New osteoporosis drug may also be useful for treating brittle bone disease

ATI Physical Therapy acquires Flexeon Rehabilitation

WGU Texas announces new scholarship program for nurses

New Orthopaedic & Spine Center guide discusses conservative treatment options for hip, knee and spine pain

Northwestern Medicine opens multidisciplinary treatment center for patients battling Huntington's disease

Study suggests possible role for caffeine in AD treatment

Good Samaritan Hospital's Stroke Program certified as primary stroke center

ITOCHU CHEMICAL FRONTIER makes strategic investment in SCILEX Pharmaceuticals

Aspen Dental to open five new locations in Arkansas in 2015

New web-based platform launched to provide acne care to patients across Pennsylvania

MOVANTIK (naloxegol) now available in U.S. for treatment of OIC in adult patients with non-cancer pain

Jacoti releases first FDA-registered medical device hearing aid application for smartphones

Mylan announces U.S. launch of Amlodipine and Valsartan Tablets

Research reveals stark variation in genetic tests for inherited eye disease in England

Moon does not influence timing of human births, hospital admissions, says UCLA scientist

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News